GO:0060577 pulmonary vein morphogenesis: Embryonic Development, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060577 pulmonary vein morphogenesis describes the developmental process that builds and organizes the pulmonary veins, the vessels that carry oxygenated blood from the lungs to the left atrium.
• Human embryo and early fetal studies show that pulmonary vein morphogenesis involves the incorporation of a pulmonary venous plexus into the left atrium and the formation of the left atrial appendage.
• The pulmonary venous endothelium is a dynamic, plastic lineage that can contribute to other cardiovascular cell types during development.
• Disrupted pulmonary vein morphogenesis is linked to congenital pulmonary vein stenosis, a condition associated with prematurity and congenital heart disease.
• Early fetal echocardiography can detect pulmonary vein anomalies, highlighting the clinical importance of understanding normal morphogenesis.
• Research on pulmonary vein morphogenesis uses developmental models, lineage tracing, and CRISPR-based gene editing to identify causal genes and mechanisms.
Description
Pulmonary vein morphogenesis (GO:0060577) is the biological process that generates and organizes the anatomical structure of the pulmonary veins, the blood vessels that transport oxygenated blood from the lungs to the heart. This process is essential for establishing the pulmonary circulation after birth, and its disruption can lead to congenital cardiovascular defects such as pulmonary vein stenosis. Understanding the cellular and molecular mechanisms of pulmonary vein morphogenesis is therefore critical for developmental biologists, cardiologists, and researchers studying congenital heart disease. Recent studies in human embryos and early fetuses have begun to define the precise timing and morphological events of pulmonary vein development, including the incorporation of the pulmonary venous plexus into the left atrium. In parallel, work on the pulmonary venous endothelium has revealed unexpected lineage plasticity, suggesting that these cells can contribute to multiple cardiovascular lineages during development. These findings underscore the importance of GO:0060577 as a framework for investigating normal and abnormal pulmonary vascular development.
pulmonary vein morphogenesis At A Glance
| GO ID | GO:0060577 |
|---|---|
| GO term | pulmonary vein morphogenesis |
| Ontology | biological_process |
| Synonym | pulmonary venous blood vessel morphogenesis |
| Major function | Generation and organization of the anatomical structure of pulmonary veins |
| Related anatomy | Pulmonary veins, left atrium, pulmonary venous plexus |
| Associated disease | Pulmonary vein stenosis, congenital heart disease |
| Key developmental window | Human embryonic and early fetal stages |
What Is GO:0060577?
GO:0060577 pulmonary vein morphogenesis is defined as the process in which the anatomical structure of the pulmonary venous blood vessels is generated and organized. Pulmonary veins are blood vessels that transport blood from the lungs to the heart. This term encompasses the cellular and molecular events that pattern, grow, and remodel the pulmonary veins during embryonic and fetal development.
Why Is pulmonary vein morphogenesis Important in Cell Biology?
Pulmonary vein morphogenesis is critical because defects in this process can cause pulmonary vein stenosis, a progressive vascular disease that is particularly severe in premature infants and children with congenital heart disease. Understanding the normal developmental program of pulmonary vein formation provides a baseline for identifying the genetic and environmental factors that disrupt it, and for developing targeted therapies. Moreover, the pulmonary venous endothelium exhibits lineage plasticity, which has implications for regenerative medicine and for understanding how cardiovascular cell fates are specified.
• Pulmonary vein morphogenesis establishes the pulmonary circulation, which is essential for oxygenation after birth.
• Disrupted pulmonary vein development is associated with congenital pulmonary vein stenosis.
• Prematurity and congenital heart disease are major risk factors for pulmonary vein stenosis, highlighting the clinical relevance of this process.
• Early fetal echocardiography can detect pulmonary vein anomalies, enabling prenatal diagnosis and counseling.
• The pulmonary venous endothelium is a dynamic lineage with plasticity, contributing to cardiovascular development.
• Animal and human studies of pulmonary vein morphogenesis inform our understanding of left atrial development.
• Genes involved in ciliogenesis and planar polarity have been linked to biliary atresia, suggesting shared developmental mechanisms with pulmonary vein morphogenesis.
• Fetal hemodynamics influence cardiovascular development, including pulmonary vein formation.
• Research on pulmonary vein morphogenesis can identify therapeutic targets for pulmonary vascular diseases.
• CRISPR-based models enable functional testing of candidate genes in pulmonary vein development.
What Happens During pulmonary vein morphogenesis?
Formation of the pulmonary venous plexus
In simple terms: First, a network of small blood vessels forms in the developing lung region.
During early embryonic development, a primitive pulmonary venous plexus emerges from the splanchnic mesoderm and connects to the developing lung buds. Studies in human embryos show that this plexus is present by the end of the embryonic period and begins to remodel into larger vessels. The plexus serves as the precursor for the definitive pulmonary veins, and its proper formation is essential for subsequent steps of pulmonary vein morphogenesis.
Incorporation into the left atrium
In simple terms: The vessel network then merges with the upper chamber of the heart.
A key event in pulmonary vein morphogenesis is the incorporation of the pulmonary venous plexus into the left atrium. Human embryo studies demonstrate that the common pulmonary vein is absorbed into the left atrial wall, resulting in the opening of individual pulmonary veins into the atrium. This process involves coordinated growth and remodeling of both the venous plexus and the atrial myocardium, and defects in this step can lead to anomalous pulmonary venous connections.
Remodeling and maturation of pulmonary veins
In simple terms: The veins then mature into their final structure with distinct walls.
After incorporation, the pulmonary veins undergo remodeling to form distinct vessel walls with endothelial, smooth muscle, and adventitial layers. This maturation is essential for withstanding the pressures of the pulmonary circulation after birth. The pulmonary venous endothelium exhibits dynamic behavior and lineage plasticity during this phase, contributing to the cellular diversity of the vessel wall.
Left atrial appendage morphogenesis
In simple terms: The small pouch of the heart's upper chamber also forms alongside the veins.
Pulmonary vein morphogenesis is closely associated with the development of the left atrial appendage. Human embryo and early fetal studies show that the left atrial appendage forms concurrently with the pulmonary veins, and both structures derive from the same region of the embryonic heart. This coordinated development ensures proper alignment of the pulmonary veins with the left atrium.
Molecular regulation by ciliogenesis and planar polarity genes
In simple terms: Specific genes control the direction and shape of the developing veins.
Recent genetic studies have implicated ciliogenesis and planar polarity effector genes in developmental processes that may also affect pulmonary vein morphogenesis. For example, variants in these genes are associated with biliary atresia, a developmental defect of the biliary tree, suggesting shared mechanisms in tubular organ morphogenesis. While direct evidence for these genes in pulmonary vein morphogenesis is still emerging, their roles in ciliary function and cell polarity are likely relevant to vascular patterning.
Key Genes Involved in GO:0060577 pulmonary vein morphogenesis
The following genes and proteins have been implicated in pulmonary vein morphogenesis or related developmental processes based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PITX2 | Left-right asymmetry and pulmonary vein patterning | Associated with atrial fibrillation and pulmonary vein development |
| TBX5 | Heart and limb development | Mutations cause Holt-Oram syndrome with pulmonary vein anomalies |
| NKX2-5 | Cardiac transcription factor | Essential for heart development and pulmonary vein formation |
| VEGFA | Angiogenesis and vascular patterning | Regulates pulmonary vascular development |
| NOTCH1 | Cell fate specification in endothelium | Involved in pulmonary venous endothelium plasticity |
| SOX17 | Endothelial cell specification | Regulates pulmonary vein endothelial identity |
| COUP-TFII | Venous identity and remodeling | Controls pulmonary vein development |
| EPHB4 | Venous endothelial patterning | Required for vascular morphogenesis |
| DLL4 | Notch signaling in angiogenesis | Modulates pulmonary vascular development |
| CC2D2A | Ciliogenesis and planar polarity | Associated with biliary atresia and developmental defects |
| PKHD1L1 | Ciliary function | Linked to ciliogenesis and planar polarity |
| WDR19 | Intraflagellar transport | Ciliopathy gene with potential vascular roles |
| ZIC3 | Left-right patterning | Heterotaxy and pulmonary vein anomalies |
| GATA4 | Cardiac development | Regulates pulmonary vein myocardium |
| HAND2 | Cardiac transcription factor | Involved in atrial and pulmonary vein development |
| MEF2C | Cardiac transcription factor | Regulates vascular smooth muscle differentiation |
| TGFBR2 | TGF-beta signaling | Modulates pulmonary vascular remodeling |
How Is pulmonary vein morphogenesis Regulated?
Pulmonary vein morphogenesis is regulated by a combination of genetic and hemodynamic factors. Fetal hemodynamics, including blood flow and pressure, influence the remodeling of the pulmonary venous plexus. Transcription factors such as PITX2, NKX2-5, and TBX5 control the expression of genes required for pulmonary vein patterning and incorporation into the left atrium. Signaling pathways including VEGF, Notch, and TGF-beta regulate endothelial cell behavior and smooth muscle investment during vessel maturation. Additionally, ciliogenesis and planar polarity effector genes may coordinate cell polarity and directional growth during pulmonary vein morphogenesis.
pulmonary vein morphogenesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PITX2 | Atrial fibrillation and pulmonary vein anomalies | Knockout mouse and iPSC-derived endothelial cells |
| NKX2-5 | Congenital heart disease with pulmonary vein defects | Knock-in mouse models and patient-derived iPSCs |
| ZIC3 | Heterotaxy and anomalous pulmonary venous return | Zebrafish knockout and mouse models |
| CC2D2A | Biliary atresia and ciliopathies | CRISPR knockout in organoids and zebrafish |
| VEGFA | Pulmonary vascular remodeling | Conditional knockout mouse and endothelial cell culture |
Pulmonary vein stenosis
Pulmonary vein stenosis is a progressive vascular disease characterized by narrowing of the pulmonary veins, leading to pulmonary hypertension and heart failure. It is strongly associated with prematurity and congenital heart disease, and outcomes remain poor in severe cases. Disrupted pulmonary vein morphogenesis during fetal development is thought to contribute to the pathogenesis of this condition. Early fetal echocardiography can detect pulmonary vein abnormalities, allowing for timely intervention.
Congenital heart disease and heterotaxy
Abnormal pulmonary vein morphogenesis is a feature of several congenital heart defects, including anomalous pulmonary venous connections and heterotaxy syndromes. Mutations in genes such as ZIC3, PITX2, and NKX2-5 have been linked to these conditions. Understanding the developmental basis of pulmonary vein morphogenesis is essential for diagnosing and managing these complex disorders.
Biliary atresia and shared developmental mechanisms
Biliary atresia, a progressive inflammatory cholangiopathy, has been associated with polygenic susceptibility in ciliogenesis and planar polarity effector genes. These same pathways may influence pulmonary vein morphogenesis, suggesting that common developmental mechanisms underlie diverse tubular organ defects. This highlights the importance of studying pulmonary vein morphogenesis in the context of broader developmental biology.
From pulmonary vein morphogenesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the role of a candidate gene in pulmonary vein morphogenesis? | CRISPR knockout in mouse embryos or zebrafish |
| How does a specific point mutation affect pulmonary vein development? | Knock-in mouse model with the patient mutation |
| What is the lineage contribution of pulmonary venous endothelium? | Cre-lox lineage tracing in mice |
| How does overexpression of a gene alter pulmonary vein formation? | Transgenic overexpression in zebrafish or mouse |
| What are the transcriptomic changes during pulmonary vein morphogenesis? | Single-cell RNA sequencing of embryonic hearts |
| Can a drug rescue pulmonary vein stenosis in a model? | Patient-derived iPSC endothelial cells and mouse models |
How to Study the pulmonary vein morphogenesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lineage tracing | Cell fate and contribution | Tracking pulmonary venous endothelium in mice |
| Single-cell RNA-seq | Gene expression heterogeneity | Identifying novel regulators of pulmonary vein morphogenesis |
| CRISPR knockout | Gene function loss | Testing candidate genes in zebrafish and mice |
| Fetal echocardiography | Pulmonary vein anatomy and flow | Prenatal diagnosis of pulmonary vein stenosis |
| Histological reconstruction | Embryonic morphology | Mapping human pulmonary vein development |
| Hemodynamic measurements | Blood flow and pressure | Assessing fetal circulation |
| Immunofluorescence | Protein localization | Validating gene expression in developing veins |
| Organoid culture | Self-organization of vascular cells | Modeling pulmonary vein development in vitro |
Lineage tracing and imaging
Lineage tracing using Cre-lox systems in mice allows researchers to follow the fate of pulmonary venous endothelial cells during development. Combined with confocal or light-sheet microscopy, this approach reveals the dynamic behavior and plasticity of the pulmonary venous endothelium. Human embryo studies using histological reconstruction provide complementary insights into the timing of pulmonary vein incorporation into the left atrium.
Transcriptomics and single-cell analysis
Single-cell RNA sequencing of developing hearts and lungs can identify the gene expression programs that drive pulmonary vein morphogenesis. This method has been used to characterize the heterogeneity of pulmonary venous endothelial cells and to discover novel regulators. Comparative transcriptomics between normal and mutant embryos can pinpoint pathways disrupted in disease models.
Genetic manipulation in animal models
Zebrafish and mouse models are widely used to study pulmonary vein morphogenesis. CRISPR-Cas9 knockout, knock-in, and overexpression approaches enable functional testing of candidate genes. For example, knockout of ciliogenesis genes in zebrafish can reveal defects in vascular patterning. These models are essential for establishing causality between gene variants and pulmonary vein phenotypes.
Fetal echocardiography and clinical imaging
Early fetal echocardiography is a non-invasive method to assess pulmonary vein anatomy and flow in human fetuses. It can detect pulmonary vein stenosis and other anomalies before birth, providing valuable diagnostic information. This technique also helps correlate prenatal findings with postnatal outcomes.
How CRISPR Can Be Used to Study GO:0060577 pulmonary vein morphogenesis
Knockout
CRISPR-Cas9 knockout is used to completely ablate candidate genes in animal models or cell lines to assess their requirement for pulmonary vein morphogenesis. For example, knocking out ciliogenesis genes in zebrafish can reveal defects in vascular patterning. Knockout models help distinguish essential from redundant genes.
Point Mutation
Point mutations identified in patients with pulmonary vein stenosis or congenital heart disease can be introduced into model organisms using CRISPR base editing or homology-directed repair. These models allow researchers to study the functional impact of specific variants on pulmonary vein development.
Knock-in
Knock-in of reporter genes or epitope tags into endogenous loci enables visualization and biochemical analysis of proteins involved in pulmonary vein morphogenesis. For example, tagging NKX2-5 or PITX2 with fluorescent proteins allows live imaging of their expression during development.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression can drive candidate genes at high levels to test sufficiency in pulmonary vein morphogenesis. Overexpression of VEGFA or NOTCH1 in endothelial cells can promote angiogenic sprouting and remodeling.
How EDITGENE Supports pulmonary vein morphogenesis Research
Researchers studying pulmonary vein morphogenesis-related genes often need to determine whether a candidate gene is causally involved in the developmental process or whether its variants contribute to disease. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this functional validation, from knockout to precise point mutations and overexpression models.
Contact EDITGENE today to design your custom CRISPR model for pulmonary vein morphogenesis research.
Frequently Asked Questions About pulmonary vein morphogenesis
What is pulmonary vein morphogenesis?
Pulmonary vein morphogenesis (GO:0060577) is the developmental process that generates and organizes the anatomical structure of the pulmonary veins, the vessels that carry blood from the lungs to the heart.
What genes are involved in pulmonary vein morphogenesis?
Key genes include PITX2, NKX2-5, TBX5, VEGFA, NOTCH1, SOX17, and COUP-TFII, among others.
What diseases are associated with abnormal pulmonary vein morphogenesis?
Disrupted pulmonary vein morphogenesis is linked to pulmonary vein stenosis, congenital heart disease, and heterotaxy syndromes.
How is pulmonary vein morphogenesis studied?
Researchers use lineage tracing, single-cell RNA sequencing, CRISPR knockout models, and fetal echocardiography to study this process.
What is the role of the pulmonary venous endothelium in development?
The pulmonary venous endothelium is a dynamic and plastic lineage that can contribute to multiple cardiovascular cell types during development.
When does pulmonary vein morphogenesis occur in humans?
It occurs during embryonic and early fetal stages, with key events such as incorporation into the left atrium occurring by the end of the embryonic period.
What is pulmonary vein stenosis?
Pulmonary vein stenosis is a progressive narrowing of the pulmonary veins that is associated with prematurity and congenital heart disease.
Can fetal echocardiography detect pulmonary vein anomalies?
Yes, early fetal echocardiography can visualize pulmonary vein anatomy and flow, aiding in prenatal diagnosis.
What model organisms are used to study pulmonary vein morphogenesis?
Zebrafish and mouse models are commonly used, along with human embryonic studies and iPSC-derived endothelial cells.
How can CRISPR help study pulmonary vein morphogenesis?
CRISPR enables knockout, knock-in, point mutation, and overexpression models to test the function of candidate genes in pulmonary vein development.
Conclusion
Pulmonary vein morphogenesis (GO:0060577) is a fundamental developmental process that ensures proper connection of the pulmonary veins to the heart. Research in human embryos and animal models has elucidated key steps, including plexus formation, atrial incorporation, and remodeling, and has identified critical genes and pathways. Disruption of this process leads to pulmonary vein stenosis and other congenital anomalies, underscoring its clinical importance. Continued investigation using advanced CRISPR models and single-cell technologies will further unravel the mechanisms of pulmonary vein morphogenesis and inform therapeutic strategies.
References
- 1. Fukui N et al.. 2024. Morphogenesis of the pulmonary vein and left atrial appendage in human embryos and early fetuses.. J Anat 244(1):142-158 PMID: 37559438
- 2. Suresh K et al.. 2016. Lung Circulation.. Compr Physiol 6(2):897-943 PMID: 27065170
- 3. McBrien A et al.. 2019. Early fetal echocardiography.. Birth Defects Res 111(8):370-379 PMID: 30430770
- 4. Wong J et al.. 2024. Dynamic behavior and lineage plasticity of the pulmonary venous endothelium.. Nat Cardiovasc Res 3(12):1584-1600 PMID: 39653825
- 5. Glessner JT et al.. 2023. Biliary atresia is associated with polygenic susceptibility in ciliogenesis and planar polarity effector genes.. J Hepatol 79(6):1385-1395 PMID: 37572794
- 6. Drossner DM et al.. 2008. Pulmonary vein stenosis: prematurity and associated conditions.. Pediatrics 122(3):e656-61 PMID: 18762500
- 7. Brezinka C. 2001. Fetal hemodynamics.. J Perinat Med 29(5):371-80 PMID: 11723838
- 8. DiLorenzo MP et al.. 2019. Pulmonary Vein Stenosis: Outcomes in Children With Congenital Heart Disease and Prematurity.. Semin Thorac Cardiovasc Surg 31(2):266-273 PMID: 30278272
